International Health Policy Program, Ministry of Public Health, Nonthaburi, Thailand.
National Health Security Office, Bangkok, Thailand.
Int J Health Policy Manag. 2020 Apr 1;9(4):133-137. doi: 10.15171/ijhpm.2019.96.
Benefit package is crucial for implementing universal health coverage (UHC). This editorial analyses how the benefit package of the Thai Universal Coverage Scheme (UC Scheme) evolved from an implicit comprehensive package which covered all conditions and interventions (with a few exceptions), to additional explicit positive lists. In 2002 when the Thai UC Scheme was launched; the comprehensive benefit package, including medicines in the national essential list of medicines, formerly offered by the previous schemes were pragmatically adopted. Later, when capacities of producing evidence on health technology assessment (HTA) increased, rigorous assessment of cost effectiveness is mandatorily required for inclusion of new interventions into the Thai UC Scheme benefit package. This contributed to evidence-informed policy decisions. To prevent emptied promises, whichever policy choices are made about the benefit package, either using a negative or a positive list, developing country governments need to make quality health services available and accessible by the entire population. Political decision on benefit package should be informed by evidence on cost effectiveness, equity dimension and health system capacity to deliver equitable services. Low- and middle-income countries need to strengthen HTA capacity to generate evidence and inform policies.
福利套餐对于实施全民健康覆盖(UHC)至关重要。本社论分析了泰国全民覆盖计划(UC 计划)的福利套餐如何从涵盖所有条件和干预措施(少数例外)的隐含综合套餐演变为额外的明确正面清单。2002 年,泰国 UC 计划启动时,以前各计划提供的国家基本药物清单中的药品等实用综合福利套餐被采用。后来,随着对卫生技术评估(HTA)证据生产能力的提高,必须对新干预措施纳入泰国 UC 计划福利套餐进行严格的成本效益评估。这有助于为政策决策提供循证依据。为了防止空口承诺,无论使用负面清单还是正面清单,制定有关福利套餐的政策选择,发展中国家政府都需要通过全民提供和获得优质的卫生服务。关于福利套餐的政治决策应参考成本效益、公平维度和卫生系统提供公平服务的能力方面的证据。中低收入国家需要加强 HTA 能力,以生成证据并为政策提供信息。